US 11655286
Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11655286 (Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/40, A61K45/06